SEC Form 4 Summary NBIX

NBIX Director Gary A. Lyons Sells 15,000 Shares

Neurocrine Biosciences director Gary A. Lyons sold 15,000 NBIX shares for $2,473,030.01 in four transactions on Nov. 17, 2026.

Transaction Value:
$2,473,030.01
Shares transacted:
15,000
Average price:
$164.87
Insider:

The Form 4 filing, an SEC report of an insider's stock trades, was filed on Nov. 19, 2026. It covers trades made two days earlier, on Nov. 17, by Neurocrine Biosciences (NBIX) director Gary A. Lyons.

Transaction details

Transaction
Date of Earliest Transaction2026-11-17
Date of Latest Transaction2026-11-17
Buy/Sellsell
Transaction Count4
Shares Transacted15,000
Price$164.87
Total Transaction Value$2,473,030.01
Insider
Ticker SymbolNBIX
CompanyNEUROCRINE BIOSCIENCES INC
Insider NameLYONS GARY A
Insider TitleDirector
Sector - IndustryHealthcare - Drug Manufacturers - Specialty & Generic
Holdings
Total Shares Owned After Transaction122,141
Position Size Change10.94%
Filing
Filing Date2026-11-19
SEC LinkView filing

FAQ

What type of transaction is this?

These were sales of company shares, reported with SEC transaction code S. The report covers four sale transactions by one insider, Gary A. Lyons. They appear in a single filing.

What was the average price of the transaction?

The average sale price was $164.87 per share across the four transactions. Separate prices for each sale are not available in the transaction details.

How did this transaction affect the insider's holdings?

Gary A. Lyons sold 15,000 shares and reported owning 122,141 shares afterward. The sales represented 10.94% of the shares he owned before the sales.

What's the total transaction value?

The total value was $2,473,030.01 for all four sales combined.

Are there any special circumstances around this transaction?

The filing information identifies a reference to a Rule 10b5-1 trading plan. These plans set stock-trading instructions in advance. The available details do not confirm which of the four sales the reference covers. Footnote text and plan terms were not available, so the plan's start date and trading schedule remain unknown.

For research purposes only; not investment advice.

Follow the Newswire
Feedly RSS feed
About RSS

Get new articles in your feed reader as they are published. Add our RSS feed to Feedly or another RSS reader.

Instant SEC Form 4 alerts

Get the next insider trade alert in real time.

Follow the filings behind the headlines. Get matching insider trade alerts sent straight to your email or Telegram, with links to the original SEC filings. Choose Premium for instant alert delivery and ticker-level filters.

Try instant alerts free 10 trading days · No credit card required

Pricing

Free Trial

10 trading days
$0

Explore every Premium feature before you pay.

  • Full platform access
  • 10 trading days
  • No credit card required
  • 20 years of alert history
  • Live alert directory updates
Start your free trial

Standard Monthly

Scheduled
$19.99 / month

Scheduled alerts with complete trade context.

  • Email and Telegram delivery
  • Alert intervals from every sixty minutes to once daily
  • Filter by insider title, buy/sell, transaction value, DRIP, ESPP, 10b5-1, and tax liability coverage transfers
  • Highlighted cluster transactions and SEC filing links
  • Access to the alert directory hourly refreshes
Choose Standard Monthly

Premium Monthly

Recommended
$29.99 / month

Fastest alerts with ticker-level control.

Choose Premium Monthly
Student discount: Customers who sign up with a verified .edu email address receive 50% off for the first four years. On monthly plans, the first month is the full 75% off.
Alerts are based on public SEC filings and are provided for informational purposes only; they do not constitute financial advice.